Pharma Mar SA
MAD:PHM
Pharma Mar SA
Interest Income Expense
Pharma Mar SA
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pharma Mar SA
MAD:PHM
|
Interest Income Expense
€2.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Grifols SA
MAD:GRF
|
Interest Income Expense
-€332.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Oryzon Genomics SA
MAD:ORY
|
Interest Income Expense
-€1.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Biotechnology Assets SA
MAD:BST
|
Interest Income Expense
-€333.9k
|
CAGR 3-Years
2%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is Pharma Mar SA's Interest Income Expense?
Interest Income Expense
2.4m
EUR
Based on the financial report for Mar 31, 2024, Pharma Mar SA's Interest Income Expense amounts to 2.4m EUR.